维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="ERION D M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	The hepatoselectiveglucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats 显示文摘	Erion D M Lapworth A Amor P A	2014	PLoS One2014，9，97：	1
2	Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes显示文摘	VANPOELJE P D DANG Q ERION M D	2007	Curr Opin Drug Discov Devel2007，10，4：	1
3	Hypoglycaenfic effect of AICAriboside in mice显示文摘	Vincent M F Erion M D ( ruber H E el al	1996	Diabetolog4a1996，39，10：	1
4	The role of peroxisome proliferator-activated receptorγ coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance 显示文摘	Nagai Y Yonemitsu S Erion D M	2009	Cell Metab2009，9，3：	1
5	Fructose-1, 6-bi- sphosphatase as a therapeutic target for type 2 diabetes 显示文摘	VAN POELJE P D DANG Q ERION M D	2007	Drug Discov Today2007，4，2：	1
6	Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease显示文摘	KUMASHIRO N ERION D M ZHANG D	2011	PNAS2011，108，16：	1
7	Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease显示文摘	Kumashiro N Erion D M Zhang D	2011	Proceedings of the National Academy of Sciences2011，108，16：	1
8	The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance显示文摘	Nagai Y Yonemitsu S Erion D M	2009	Cell Metab2009，9，3：	1
9	SIRT1 regulates adipose tissue inflammation 显示文摘	GILLUM M P KOTAS M E ERION D M	2010	Dia-betes2010，60，12：	1
10	Liver-targeted drug delivery using HepDirect prodrugs显示文摘	Erion M D van Poelje P D Mackenna D A et a1	2005	J Pharmacol Exp Ther2005，312，2：	1
11	The role of peroxisome proliferator-activated receptoR gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance显示文摘	Nagai Y Yonemitsu S Erion D M	2009	Cell Metab2009，9，3：	1
12	Prodrugs of phosphates and phosphonates显示文摘	Hecker S J Erion M D	2008	J Med Chem2008，51，8：	1
13	Structure- guided design of AMP mimics that inhibit fructose-I, 6-bisphosphatase with high affinity and specificity显示文摘	Erion M D Dang Q Reddy M R	2007	Journal of the American Chemical Society2007，129，15：	1
14	Sirtl knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats显示文摘	ERION D M YONEMITSU S NIE Y	2009	Proc Natl Acad Sci USA2009，106，11：	1
15	Liver-targeted drug delivery using HepDirect prodrugs显示文摘	Erion M D van Poelje P D Mackenna D A	2005	J Pharmacol Exp Ther2005，312，2：	1
16	Sirtl knockdown in liver decreases basal hepatic glucose production and increases he- patic insulin responsiveness in diabetic rats显示文摘	ERION D M YONEMISTSU S NIE Y	2009	Proc Natl Acad Sci USA2009，106，11：	1
17	Prodrugs of phosphates and phosphonates显示文摘	Hecker S J Erion M D	2008	J Med Chem2008，51，：	1
18	Prevention of hepatic steatosis and hepatic in- sulin resistance by knockdown of cAMP response element-binding protein 显示文摘	Erion D M Ignatova I D Yonemitsu S	2009	Cell Metab2009，10，：	1
19	Design, synthesis, and characterization of a series of cytochrome P450 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver显示文摘	Erion M D Reddy K R Boyer S H	2004	J Am Chem Soc2004，126，：	1
20	L iver-targeted drug delivery us ing hepDirect prodrugs显示文摘	Erion M D Van Poelje Mackenna D A	2005	J Pharm Exp Ther2005，312，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示